Alan Nurden: Looking Beyond Bleeding in VWD
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared on LinkedIn about a recent article by Dawn Swan et al, published in RPTH Journal:
”A well thought-out and much-needed assessment of the effects of VWD extending beyond the classical bleeding symptoms.
Could someone now do this for the platelet-based bleeding disorder, Glanzmann thrombasthenia (GT)?
And for GT it would be interesting to go beyond well-studied European and North American populations to include Arab, Pakistani, Indian, Chinese, African and South-American populations where cultural and religious heritage may have a bearing on lifestyle.
A complication of GT is that two genes are involved (ITGA2B and ITGB3) and despite hints from older studies the question of whether ITGB3 defects that lead to both alphaIIbbeta3 and alphavbeta3 deficiencies can influence such parameters as bone density and fertility remain unresolved.”
Title: Von Willebrand disease: more than just a bleeding disorder
Authors: Dawn Swan, Michelle Sholzberg, Bethany Samuelson Bannow, Jecko Thachil
Read the Full Article on RPTH Journal

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk